Patents by Inventor Oswald Tauber

Oswald Tauber has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antiphlogistic pharmaceutical compositions and method of use
    Patent number: 4292319
    Abstract: Pharmaceutical compositions containing a non-steroidal anti-inflammatory compound and 5,11-dihydro-11-[(4-methyl-1-piperazinyl)-acetyl]-6H-pyrido[2,3-b]-[1,4]be nzodiazepin-6-one or a non-toxic acid addition salt thereof, and a method of using the same as antiphlogistics; the pyridobenzodiazepinone ingredient effectively suppresses the gastro-intestinal side-effects of the anti-inflammatory ingredient.
    Type: Grant
    Filed: July 14, 1980
    Date of Patent: September 29, 1981
    Assignee: Boehringer Ingelheim GmbH
    Inventors: Oswald Tauber, Gunther Engelhardt, Matyas Leitold, Gunther Schmidt
  • Antiphlogistic pharmaceutical compositions and method of use
    Patent number: 4256747
    Abstract: Pharmaceutical compositions containing a non-steroidal anti-inflammatory compound and 5,11-dihydro-11-[(4-methyl-1-piperazinyl)-acetyl]-6H-pyrido[2,3-b]-[1,4]be nzodiazepin-6-one or a non-toxic acid addition salt thereof, and a method of using the same as antiphlogistics; the pyridobenzodiazepinone ingredient effectively suppresses the gastro-intestinal side-effects of the anti-inflammatory ingredient.
    Type: Grant
    Filed: March 30, 1979
    Date of Patent: March 17, 1981
    Assignee: Boehringer Ingelheim GmbH
    Inventors: Oswald Tauber, Gunther Engelhardt, Matyas Leitold, Gunther Schmidt
  • Antiphlogistic pharmaceutical composition and method of use
    Patent number: 4154833
    Abstract: Pharmaceutical compositions containing a non-steroidal anti-inflammatory compound and 5,11-dihydro-11-[(4-methyl-1-piperazinyl)-acetyl]-6H-pyrido[2,3-b]-[1,4]be nzodiazepin-6-one or a non-toxic acid addition salt thereof, and a method of using the same as antiphlogistics; the pyridobenzodiazepinone ingredient effectively suppresses the gastro-intestinal side-effects of the anti-inflammatory ingredient.
    Type: Grant
    Filed: February 17, 1978
    Date of Patent: May 15, 1979
    Assignee: Boehringer Ingelheim GmbH
    Inventors: Oswald Tauber, Gunther Engelhardt, Matyas Leitold, Gunther Schmidt